Literature DB >> 12970181

Regulation of mature T lymphocyte proliferation and differentiation by Par-4.

María José Lafuente1, Pilar Martin, Isabel Garcia-Cao, María Teresa Diaz-Meco, Manuel Serrano, Jorge Moscat.   

Abstract

The genetic inactivation of the atypical protein kinase C (aPKC) inhibitor, Par-4, gives rise to increased NF-kappaB activation and decreased stimulation of JNK in embryo fibroblasts. Here we have characterized the immunological phenotype of the Par-4(-/-) mice and found that the loss of this gene leads to an increased proliferative response of peripheral T cells when challenged through the TCR. This is accompanied by a higher increase in cell cycle entry and inhibition of apoptosis, with enhanced IL-2 secretion but normal CD25 synthesis. Interestingly, the TCR-triggered activation of NF-kappaB was augmented and that of JNK was severely abrogated. Consistent with previous data from knock outs of different JNKs, NFATc1 activation and IL-4 secretion were augmented in the Par-4-deficient CD4+ T cells, suggesting that the loss of Par-4 drives T-cell differentiation towards a Th2 response. This is compelling evidence that Par-4 is a novel modulator of the immune response through its ability to impact aPKC activity, which translates into lower JNK signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970181      PMCID: PMC212727          DOI: 10.1093/emboj/cdg460

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  23 in total

1.  Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway.

Authors:  M Leitges; L Sanz; P Martin; A Duran; U Braun; J F García; F Camacho; M T Diaz-Meco; P D Rennert; J Moscat
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

Review 2.  NFAT signaling: choreographing the social lives of cells.

Authors:  Gerald R Crabtree; Eric N Olson
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 3.  Endotoxin exposure in allergy and asthma: reconciling a paradox.

Authors:  Andrew H Liu
Journal:  J Allergy Clin Immunol       Date:  2002-03       Impact factor: 10.793

4.  Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha.

Authors:  A G Martin; B San-Antonio; M Fresno
Journal:  J Biol Chem       Date:  2001-02-15       Impact factor: 5.157

5.  Inhibition of JNK activation through NF-kappaB target genes.

Authors:  G Tang; Y Minemoto; B Dibling; N H Purcell; Z Li; M Karin; A Lin
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

6.  Role of zeta PKC in B-cell signaling and function.

Authors:  Pilar Martin; Angeles Duran; Susana Minguet; María-Luisa Gaspar; Maria-Teresa Diaz-Meco; Paul Rennert; Michael Leitges; Jorge Moscat
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

7.  Genetic inactivation of Par4 results in hyperactivation of NF-kappaB and impairment of JNK and p38.

Authors:  Isabel Garcia-Cao; María José Lafuente; Luis M Criado; María Teresa Diaz-Meco; Manuel Serrano; Jorge Moscat
Journal:  EMBO Rep       Date:  2003-03       Impact factor: 8.807

Review 8.  NF-kappaB activation by protein kinase C isoforms and B-cell function.

Authors:  Jorge Moscat; María T Diaz-Meco; Paul Rennert
Journal:  EMBO Rep       Date:  2003-01       Impact factor: 8.807

9.  c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity.

Authors:  Nathalie Arbour; Denise Naniche; Dirk Homann; Roger J Davis; Richard A Flavell; Michael B A Oldstone
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

10.  c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation.

Authors:  Dietrich Conze; Troy Krahl; Norman Kennedy; Linda Weiss; Joanne Lumsden; Patricia Hess; Richard A Flavell; Graham Le Gros; Roger J Davis; Mercedes Rincón
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

View more
  14 in total

1.  Unraveling the molecular targets pertinent to junction restructuring events during spermatogenesis using the Adjudin-induced germ cell depletion model.

Authors:  Weiliang Xia; Dolores D Mruk; Will M Lee; C Yan Cheng
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

2.  The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation.

Authors:  Pilar Martin; Maria T Diaz-Meco; Jorge Moscat
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

Review 3.  The atypical PKCs in inflammation: NF-κB and beyond.

Authors:  Maria T Diaz-Meco; Jorge Moscat
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

4.  The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.

Authors:  Yinxing Liu; Misty R Gilbert; Natasha Kyprianou; Vivek M Rangnekar; Craig Horbinski
Journal:  Acta Neuropathol       Date:  2014-08-19       Impact factor: 17.088

5.  Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.

Authors:  J T Greene; Rajeswaran Mani; Rahul Ramaswamy; Frank Frissora; Max Yano; Kevan Zapolnik; Bonnie Harrington; Ronni Wasmuth; Minh Tran; Xiaokui Mo; Mary McKenna; Vivek M Rangnekar; John C Byrd; Subbarao Bondada; Natarajan Muthusamy
Journal:  Blood Adv       Date:  2019-04-23

6.  Crosstalk between PKCzeta and the IL4/Stat6 pathway during T-cell-mediated hepatitis.

Authors:  Angeles Durán; Angelina Rodriguez; Pilar Martin; Manuel Serrano; Juana Maria Flores; Michael Leitges; María T Diaz-Meco; Jorge Moscat
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

Review 7.  Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex.

Authors:  J Moscat; M T Diaz-Meco; M W Wooten
Journal:  Cell Death Differ       Date:  2009-08-28       Impact factor: 15.828

8.  Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.

Authors:  Pablo J Fernandez-Marcos; Shadi Abu-Baker; Jayashree Joshi; Anita Galvez; Elias A Castilla; Marta Cañamero; Manuel Collado; Carmen Saez; Gema Moreno-Bueno; Jose Palacios; Michael Leitges; Manuel Serrano; Jorge Moscat; Maria T Diaz-Meco
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-26       Impact factor: 11.205

Review 9.  Apoptosis and tumor resistance conferred by Par-4.

Authors:  Yanming Zhao; Vivek M Rangnekar
Journal:  Cancer Biol Ther       Date:  2008-12-08       Impact factor: 4.742

10.  Par-4 inhibits Akt and suppresses Ras-induced lung tumorigenesis.

Authors:  Jayashree Joshi; Pablo J Fernandez-Marcos; Anita Galvez; Ramars Amanchy; Juan F Linares; Angeles Duran; Peterson Pathrose; Michael Leitges; Marta Cañamero; Manuel Collado; Clara Salas; Manuel Serrano; Jorge Moscat; Maria T Diaz-Meco
Journal:  EMBO J       Date:  2008-07-24       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.